Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Ironwood Pharmaceuticals
IRWD
$728M
| $23.3M | ﹤0.01% |
2,678,116
-1,617,520
| -38% | -$19.6M |
|
|
TSVT
2527
DELISTED
2seventy bio
TSVT
| $23.3M | ﹤0.01% |
4,357,506
-5,328,114
| -55% | -$25.1M |
|
2528
Hilton Grand Vacations
HGV
$3.52B
| $23.3M | ﹤0.01% |
492,992
-1,483,086
| -75% | -$64.9M |
|
|
PCH
2529
DELISTED
PotlatchDeltic
PCH
| $23.2M | ﹤0.01% |
493,314
-663,496
| -57% | -$30.5M |
|
2530
Calvert US Mid-Cap Core Responsible Index ETF
CVMC
$109M
| $23.1M | ﹤0.01% |
400,000
-400,000
| -50% | -$21.8M |
|
|
OPLN
2531
Openlane
OPLN
$4.36B
| $23.1M | ﹤0.01% |
1,337,362
-1,824,884
| -58% | -$27.4M |
|
2532
Ingevity
NGVT
$2.52B
| $23.1M | ﹤0.01% |
484,776
-504,026
| -51% | -$22.7M |
|
2533
Viavi Solutions
VIAV
$9.31B
| $23.1M | ﹤0.01% |
2,540,212
-2,364,184
| -48% | -$23.2M |
|
2534
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$108M
| $23.1M | ﹤0.01% |
668,921
-768,513
| -53% | -$25.8M |
|
2535
Franklin US Large Cap Multifactor Index ETF
FLQL
$2.1B
| $23.1M | ﹤0.01% |
432,932
-445,308
| -51% | -$22.5M |
|
2536
FIGS
FIGS
$1.82B
| $23M | ﹤0.01% |
4,625,959
-6,449,951
| -58% | -$37.1M |
|
2537
Diamondrock Hospitality Co
DRH
$2.74B
| $23M | ﹤0.01% |
2,392,783
-1,479,009
| -38% | -$13.8M |
|
2538
Kratos Defense & Security Solutions
KTOS
$9.73B
| $23M | ﹤0.01% |
1,250,894
-1,680,832
| -57% | -$30.6M |
|
2539
St. Joe Company
JOE
$3.64B
| $23M | ﹤0.01% |
396,559
-329,653
| -45% | -$18.2M |
|
2540
Ascendis Pharma A/S
ASND
$16B
| $23M | ﹤0.01% |
152,052
-91,700
| -38% | -$13.1M |
|
2541
Four Corners Property Trust
FCPT
$2.78B
| $22.9M | ﹤0.01% |
935,885
-891,847
| -49% | -$21.5M |
|
|
SCHR
2542
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $22.9M | ﹤0.01% |
932,676
-1,014,700
| -52% | -$24.9M |
|
2543
Noble Corp
NE
$6.45B
| $22.8M | ﹤0.01% |
471,167
-740,409
| -61% | -$33.3M |
|
2544
Republic Bancorp
RBCAA
$1.95B
| $22.8M | ﹤0.01% |
447,141
-467,603
| -51% | -$23.5M |
|
2545
Dimensional US Core Equity 2 ETF
DFAC
$49.3B
| $22.8M | ﹤0.01% |
713,131
-562,969
| -44% | -$17M |
|
2546
Arbutus Biopharma
ABUS
$861M
| $22.8M | ﹤0.01% |
8,830,297
-5,137,927
| -37% | -$13.3M |
|
2547
Avient
AVNT
$3.43B
| $22.8M | ﹤0.01% |
524,481
-500,471
| -49% | -$19.5M |
|
|
AMED
2548
DELISTED
Amedisys
AMED
| $22.8M | ﹤0.01% |
246,888
-264,474
| -52% | -$24.8M |
|
2549
Newmark Group
NMRK
$2.72B
| $22.7M | ﹤0.01% |
2,051,187
-2,082,799
| -50% | -$21.8M |
|
2550
Guardant Health
GH
$21.3B
| $22.7M | ﹤0.01% |
1,101,592
-3,814,972
| -78% | -$81.8M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.